Skip to main content Accessibility help
×
Home

Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics

  • Chun-Jen Huang (a1) (a2), Hui-Min Hsieh (a3), Hung-Pin Tu (a4), He-Jiun Jiang (a5), Peng-Wei Wang (a1) (a2) and Ching-Hua Lin (a2) (a6)...

Abstract

Background:

This study investigated the prevalence and characteristics of schizophrenia in patients with type 2 diabetes mellitus (T2DM) in Taiwan.

Methods:

National Health Insurance claims data for patients with principal diagnoses of schizophrenia and T2DM were analysed.

Results:

Compared with patients with schizophrenia in the general population (GP), those with schizophrenia and T2DM were more likely to have higher Charlson comorbidity index (CCI) scores and multiple comorbidities, and were older. The prevalence of schizophrenia was significantly higher in patients with T2DM than in the GP from 2000 to 2010. In addition, during this period, the prevalence of schizophrenia in patients with T2DM increased from 0.64% to 0.85%; such an increase in the GP was also observed. A high prevalence of schizophrenia was observed in patients with T2DM aged less than 60 years old; those residing in eastern Taiwan; those with incomes of ≤NT$17,280, NT$17,281–NT$22,880, NT$22,881–NT$28,800, and NT$36,301–NT$45,800; and those with CCI > 2.

Conclusions:

Our study found the prevalence of schizophrenia is higher in patients with T2DM than in the GP, particularly those with earlier ages less than 60 years old. Public health initiatives are necessary to prevent and treat schizophrenia in patients with T2DM, specifically for those with the aforementioned and premature death risk.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author at: Department of Psychiatry, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, 100, Shih-Chuan 1st Road, San Ming District, Kaohsiung 807, Taiwan. E-mail address: chua.lin@msa.hinet.net

References

Hide All
[1]Suvisaari, JKeinanen, JEskelinen, SMantere, ODiabetes and schizophrenia. Curr Diabetes Rep 2016; 16:16.
[2]Pedersen, CBMors, OBertelsen, AWaltoft, BLAgerbo, EMcGrath, JJ et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 2014; 71:573–81.
[3]Perälä, JSuvisaari, JSaarni, SIKuoppasalmi, KIsometsä, EPirkola, S et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64:1928.
[4]Laursen, TMMunk-Olsen, TVestergaard, MLife expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012; 25:83–8.
[5]Leng, CHChou, MHLin, SHYang, YKWang, JDEstimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan. Schizophr Res 2016; 171:97102.
[6]Hjorthoj, CSturup, AEMcGrath, JJNordentoft, MYears of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 2017; 4:295301.
[7]ADA, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 [American Dibetes Association]. Diabetes Care 2018; 41:S1327.
[8]Lin, WHHsu, CHChen, HFLiu, CCLi, CYMortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study. Diabetes Res Clin Pract 2015; 107:178–86.
[9]Amos, AFMcCarty, DJZimmet, PThe rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetes Med 14(Suppl. 5)1997; S185.
[10]Quan, JLi, TKPang, HChoi, CHSiu, SCTang, SY et al. Diabetes incidence and prevalence in Hong Kong, China during 2006–2014. Diabetes Med 2017; 34:902–8.
[11]Rajkumar, APHorsdal, HTWimberley, TCohen, DMors, OBørglum, AD et al. Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry 2017; 174:686–94.
[12]Maudsley, HThe pathology of mind 1879, Macmillan London.
[13]Andreassen, OADiabetes and schizophrenia-new findings for an old puzzle. Am J Psychiatry 2017; 174:616–7.
[14]Raphael, TParsons, JPBlood sugar studies in dementia praecox and manic-depressive insanity. Arch Neurol Psychiatry 1921; 5:687709.
[15]Ryan, MCThakore, JHPhysical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci 2002; 71:239–57.
[16]Polimanti, RGelernter, JStein, DJGenetically determined schizophrenia is not associated with impaired glucose homeostasis. Schizophr Res 2018; 195:286–9.
[17]Foley, DLMackinnon, AMorgan, VAWatts, GFCastle, DJWaterreus, A et al. Common familial risk factors for schizophrenia and diabetes mellitus. Aust N Z J Psychiatry 2016; 50:488–94.
[18]Hansen, TIngason, ADjurovic, SMelle, IFenger, MGustafsson, O et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry 2011; 70:5963.
[19]Liu, YLi, ZZhang, MDeng, YYi, ZShi, TExploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics 2013; 6:S17.
[20]Andreassen, OADjurovic, SThompson, WKSchork, AJKendler, KSO’Donovan, MC et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013; 92:197209.
[21]Chien, ICHsu, JHLin, CHBih, SHChou, YJChou, PPrevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr Res 2009; 111:1722.
[22]Hsu, JHChien, ICLin, CHChou, YJChou, PIncidence of diabetes in patients with schizophrenia: a population-based study. Can J Psychiatry 2011; 56:1926.
[23]Hung, CFWu, CKLin, PYDiabetes mellitus in patients with schizophrenia in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:523–7.
[24]Stubbs, BVancampfort, DDe Hert, MMitchell, AJThe prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 2015; 132:144–57.
[25]Vancampfort, DCorrell, CUGalling, BProbst, MDe Hert, MWard, PB et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 2016; 15:166–74.
[26]Huang, CJLin, CHLee, MHChang, KPChiu, HCPrevalence and incidence of diagnosed depression disorders in patients with diabetes: a national population-based cohort study. Gen Hosp Psychiatry 2012; 34:242–8.
[27]Huang, CJChiu, HCLee, MHWang, SYPrevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study. Gen Hosp Psychiatry 2011; 33:815.
[28]Huang, CJChiu, HCHsieh, HMYen, JYLee, MHChang, KP et al. Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study. Gen Hosp Psychiatry 2015; 37:299304.
[29]Chien, ICChou, YJLin, CHBih, SHChou, PChang, HJPrevalence and incidence of schizophrenia among National Health Insurance enrollees in Taiwan, 1996–2001. Psychiatry Clin Neurosci 2004; 58:611–8.
[30]Chien, ICChou, YJLin, CHBih, SHChou, PPrevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 2004; 55:691–7.
[31]Stubbs, BVancampfort, DDe Hert, MMitchell, AThe prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 2015; 132:144–57.
[32]Shafie, SLee, SPOng, SBCWang, PSeow, EOng, HL et al. Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore. Singapore Med J 2018 10.11622/smedj.2018020 [Epub ahead of print].
[33]Sugai, TSuzuki, YYamazaki, MShimoda, KMori, TOzeki, Y et al. High prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus in Japanese outpatients with schizophrenia: a nationwide survey. PLoS One 2016; 11:e0166429.
[34]Chang, WCWong, CSMChen, EYHLam, LCWChan, WCNg, RMK et al. Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull 2017; 43:1280–90.
[35]Aschengrau, ASeage, GR IIIEssentials of epidemiology in public health third edition 2014, Jones & Bartlett Learning MA, USA.
[36]Galletly, CAPremature death in schizophrenia: bridging the gap. Lancet Psychiatry 2017; 4:263–5.
[37]Olfson, MGerhard, THuang, CCrystal, SStroup, TSPremature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72:1172–81.
[38]Suetani, SWhiteford, HAMcGrath, JJAn urgent call to address the deadly consequences of serious mental disorders. JAMA Psychiatry 2015; 72:1166–7.
[39]Hoffman, RPThe complex inter-relationship between diabetes and schizophrenia. Curr Diabetes Rev 2017; 13:528–32.
[40]Wilding, JThe importance of weight management in type 2 diabetes mellitus. Int J Clin Pract 2014; 68:682–91.
[41]Smith, RCJin, HLi, CBark, NShekhar, ADwivedi, S et al. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study. Schizophr Res 2013; 143:1824.
[42]Liptzin, BRegier, DAGoldberg, IDUtilization of health and mental health services in a large insured population. Am J Psychiatry 1980; 137:553–8.
[43]Katon, WJRutter, CSimon, GLin, EHLudman, ECiechanowski, P et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28:2668–72.

Keywords

Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics

  • Chun-Jen Huang (a1) (a2), Hui-Min Hsieh (a3), Hung-Pin Tu (a4), He-Jiun Jiang (a5), Peng-Wei Wang (a1) (a2) and Ching-Hua Lin (a2) (a6)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics

  • Chun-Jen Huang (a1) (a2), Hui-Min Hsieh (a3), Hung-Pin Tu (a4), He-Jiun Jiang (a5), Peng-Wei Wang (a1) (a2) and Ching-Hua Lin (a2) (a6)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *